The FDA Center for Devices & Radiological Health chief Jeffrey Shuren, MD, fielded questions related to medical devices, protecting patients and promoting innovation during a congressional hearing this week, according to a MassDevice report.
Uncategorized
After last week's announcement that Siemens, Europe's largest engineering company, would exit the radiation therapy market, stocks of Varian Medical Systems, a Palo Alto-based maker of radiotherapy tools to treat cancer, rose yesterday, according to a Bloomberg Businessweek report.
Neuroscientists say the way in which patients think about pain can affect the painful experience itself, according to a Wall Street Journal report.
Opportunity Largest provider of management outsourcing services to acute care hospitals seeks a vice president, business development for ambulatory surgery centers. This leader will serve as the primary liaison between corporate and potential ASC clients. Position will support all new…
Amerinet, a national healthcare group purchasing organization, has announced it has signed an agreement with C.R. Bard for bowel management products, according to an Amerinet news release.
Amerinet, a national healthcare group purchasing organization, has announced it has signed an agreement with Medline Industries for advanced wound care products, according to an Amerinet news release.
Ohio hospitals nearly halved the incidence of central line-associated bloodstream infections in intensive care units over a 22-month period, according to an Ohio Hospital Association news release. Read the full report in Becker’s ASC Review on CLABSI in Ohio hospitals.
Given the economy and the need to stretch budgets, purchasing pre-owned equipment may prove to be a viable approach for augmenting your facility's inventory, says Ray Midlam, product manager, certified pre-owned equipment for Olympus America.
B. Braun Renal Therapies has announced enhanced offerings for its Hemodialysis System, according to a B. Braun news release.
Heart attack patients who got free medications had lower rates of rehospitalization for heart attack or heart failure compared to patients who had prescription co-pays, according to late-breaking research presented at the American Heart Association’s Scientific Sessions 2011.
